SCHEMBL30892882

SCHEMBL30892882

CCN(CC)CC.OP(=S)(Oc1ccc(Br)cc1)Oc1ccc(Br)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.39
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ BLM P54132 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ MAPT P10636 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ PYCR1 P32322 1/20 0.36
▸ SIGMAR1 Q99720 2/20 0.35
▸ EBP Q15125 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ MGLL Q99685 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29219085 0.85 MAPT (0.41) LMNABLMMAPK1RAB9AMEN1
SCHEMBL28251223 0.73 CYP2A6 (0.38) LMNAKDM4EMAPK1ALDH1A1RAB9A
SCHEMBL11670609 0.70 ALDH1A1 (0.41) LMNAKDM4EMAPK1TDP1ALDH1A1
SCHEMBL11581695 0.69 ALDH1A1 (0.58) LMNAL3MBTL1KDM4EMAPK1TDP1
SCHEMBL27977311 0.69 ALDH1A1 (0.44) LMNAL3MBTL1KDM4EMAPK1TDP1
SCHEMBL1974047 0.69 TSHR (0.54) LMNABLMKDM4ETDP1ALDH1A1
SCHEMBL10665272 0.68 MMP1 (0.51) KDM4EMAPK1TDP1ALDH1A1PYCR1
SCHEMBL30592712 0.68 LMNA (0.35) LMNAL3MBTL1KDM4EMAPK1ALDH1A1
SCHEMBL28056948 0.67 NPC1 (0.40) LMNAL3MBTL1KDM4EMAPK1ALDH1A1
SCHEMBL28032276 0.66 CYP2C19 (0.58) LMNABLMMAPK1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117897484-A Antisense oligonucleotides and their use for treating neurodegenerative disorders 卫材R&D管理有限公司 2024-04-16 — — CN disclosed
Send feedback